Davide Torti

发表

A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.

Davide Corà, Claudio Isella, Enzo Medico, 2011, Cancer discovery.

Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas

A. Bardelli, A. Muratore, L. Trusolino, 2012, Clinical Cancer Research.

Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer

L. Trusolino, A. Bertotti, G. Migliardi, 2013, Oncogene.

Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia.

D. Torti, I. Iacobucci, D. Cilloni, 2013, Leukemia research.

Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones

P. Pandolfi, R. Taulli, D. Torti, 2017, Oncotarget.

Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations

C. Isella, A. Muratore, L. Trusolino, 2011, Clinical Cancer Research.

The Role of PTEN in Myeloid Malignancies

D. Torti, C. Panuzzo, G. Saglio, 2015, Hematology reports.

Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils

L. Trusolino, D. Torti, Livio Trusolino, 2011, EMBO molecular medicine.

Early prolonged prone position in noninvasively ventilated patients with SARS-CoV-2-related moderate-to-severe hypoxemic respiratory failure: clinical outcomes and mechanisms for treatment response in the PRO-NIV study

D. Torti, E. Paschetta, G. Musso, 2022, Critical Care.

Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction

L. Trusolino, A. Bertotti, E. Medico, 2009, Science Signaling.

Only a subset of Met-activated pathways are required to sustain oncogene addiction.

L. Trusolino, A. Bertotti, E. Medico, 2009, Science signaling.

The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias

R. Taulli, D. Torti, D. Cilloni, 2016, Oncotarget.

Cancer Therapy : Preclinical InhibitionofMEKandPI 3 K / mTORSuppressesTumorGrowth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas

A. Muratore, L. Trusolino, A. Bertotti, 2012 .

Inhibition of Src Impairs the Growth of Met-Addicted Gastric Tumors

P. Elvin, L. Trusolino, A. Bertotti, 2010, Clinical Cancer Research.

Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion

M. Papotti, R. Taulli, D. Torti, 2015, Oncotarget.

New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia

D. Torti, C. Panuzzo, G. Saglio, 2015, Oncoscience.

Inhibition of Src Impairs the Growth of Met-Addicted Gastric Tumors

P. Elvin, L. Trusolino, A. Bertotti, 2010, Clinical Cancer Research.

Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction

L. Trusolino, A. Bertotti, E. Medico, 2009, Science Signaling.

Diffusion‐weighted quantitative MRI to diagnose benign conditions from malignancies of the anterior mediastinum: Improvement of diagnostic accuracy by comparing perfusion‐free to perfusion‐sensitive measurements of the apparent diffusion coefficient

D. Torti, A. Priola, A. Veltri, 2016, Journal of magnetic resonance imaging : JMRI.

A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors

L. Trusolino, A. Bertotti, F. Sassi, 2012, International Journal of Cancer.

New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia

C. Panuzzo, G. Saglio, G. Volpe, 2015, Oncoscience.

Methoxyflurane Versus Standard of Care for Acute Trauma-Related Pain in the Emergency Setting: Protocol for a Randomised, Controlled Study in Italy (MEDITA)

D. Torti, A. Fabbri, G. Carpinteri, 2018, Advances in Therapy.